Markets

Insider Trading

Hedge Funds

Retirement

Opinion

15 Highest Paying Countries for Biomedical Engineers

In this article, we will look at the 15 highest paying countries for biomedical engineers. We have also discussed the global bioengineering technology market. If you want to skip our detailed analysis, head straight to the 5 Highest Paying Countries for Biomedical Engineers

The global Bioengineering Technology Market exhibited remarkable growth, with a value of $239.1 billion in 2022, projected to increase at a strong CAGR of 12.3% from 2023 to 2029, reaching a $538.56 billion. This expansion is fueled by developments in various sectors, such as healthcare, technology, and environmental sciences. Bioengineering, integrating biology with engineering principles, offers solutions across different industries like pharmaceuticals, agriculture, and natural resources and thus, promotes innovation that drives market growth.

Investments in bioengineering are catalyzing transformative changes in healthcare, facilitating enhanced diagnosis, treatment, and biomedical solutions. The market landscape is shaped by key players such as Abbott Laboratories (NYSE:ABT) and GE Healthcare Technologies Inc (NASDAQ:GEHC) capitalizing on cutting-edge technologies to sustain their market positions and drive innovation. With global investments in synthetic biology surpassing $4.6 billion in the first quarter of 2021, emerging biotechnological platforms like precision medicine and gene therapies are set to reshape the bioengineering technology landscape.

Speaking of key players, it is worth highlighting that Abbott Laboratories (NYSE:ABT) recently introduced its groundbreaking Aveir dual-chamber leadless pacemaker technology, with the first US commercial implantations completed. Having received FDA approval in July 2023, the Aveir system became the first of its kind to gain regulatory clearance for treating abnormal or slow heart rhythms. This innovation by Abbott Laboratories (NYSE:ABT) addresses a major clinical need, as over 80% of individuals requiring a pacemaker necessitate pacing in two chambers of the heart—the right atrium and right ventricle.

The Aveir system, recognized as one of Time magazine’s best inventions of 2023, incorporates Abbott Laboratories (NYSE:ABT)’s proprietary i2i communication technology. This feature enables synchronized cardiac pacing between two leadless pacemakers, enhancing patient outcomes. Notably, the Aveir DR devices, smaller than a AAA battery, communicate beat-to-beat with each other, utilizing the body’s conductive properties to relay messages. Today, there are 114,000 employees working for Abbott Laboratories (NYSE:ABT) that are dedicated to making a lasting impact on global health across more than 160 countries served.

On the other hand, GE Healthcare Technologies Inc (NASDAQ:GEHC), one of the highest paying biomedical engineering companies, has recently announced the publication of data showing the effectiveness of its artificial intelligence (AI) models in predicting patient responses to immunotherapies. This study utilized clinical data to accurately predict the efficacy and toxicity of cancer immunotherapy treatments. The AI models developed by GE Healthcare Technologies Inc (NASDAQ:GEHC) demonstrated an accuracy range of 70% to 80% across a pan-cancer sample.

GE Healthcare Technologies Inc (NASDAQ:GEHC) collaborated with Vanderbilt University Medical Center (VUMC) to retrospectively examine and correlate immunotherapy responses for thousands of cancer patients. They utilized de-identified genetic, cellular, proteomic, tumor, genomic, and imaging data from patients to create these models. 

According to Bureau of Labor Statistics, for bioengineering and biomedical engineering, a bachelor’s degree in bioengineering or biomedical engineering is typically required, with no prior work experience or on-the-job training needed. The median annual pay in 2022 was $99,550 or $47.86 per hour. To read about high-paying countries for engineers, see the countries that pay engineers the most. The job prospects for biomedical engineering are also promising, with a 5% growth projected from 2022 to 2032, adding 1,000 new jobs. To read more about fastest growing jobs, see the Fastest Growing Jobs In America. It is worth highlighting that clinical engineers are one of the highest paying bioengineering jobs.

It is also interesting to note that the field of biomedical technology is rapidly advancing, with graphene-based innovations at the forefront. Graphene’s unique properties such as flexibility, electrical conductivity, and biocompatibility, make it an ideal material for various medical applications. One notable development is INBRAIN Neuroelectronics’ implantable neural platform, which utilizes graphene for decoding and modulating neural activity. These graphene interfaces offer advantages over traditional metal-based implants, such as improved flexibility and reduced invasiveness, potentially revolutionizing treatments for conditions like Parkinson’s and epilepsy.

Additionally, graphene-based electrodes are enhancing diagnostic techniques, such as electroretinography for eye conditions. Researchers have developed flexible graphene electrodes that improve patient comfort and offer superior recording capabilities compared to traditional gold electrodes. Moreover, graphene-based biosensors are being integrated into wearable devices, such as wound monitoring patches and infection screening tools, showcasing the versatility of graphene in healthcare applications.

Scientist in a lab working on a research project, focusing on biotechnology and healthcare advancements.

Our Methodology

To list the highest paying countries for biomedical engineers, we identified the countries with the highest demand for biomedical engineers and then made a list for 25 countries with the average salaries for biomedical engineers. Of those 25, the 15 with the highest average salaries were selected and have been ranked. We acquired the data for average salaries of biomedical engineers for each country from ERI Economic Research Institute. The list is presented in ascending order.

By the way, Insider Monkey is an investing website that uses a consensus approach to identify the best stock picks of more than 900 hedge funds investing in US stocks. The website tracks the movement of corporate insiders and hedge funds. Our top 10 consensus stock picks of hedge funds outperformed the S&P 500 stock index by more than 140 percentage points over the last 10 years (see the details here). So, if you are looking for the best stock picks to buy, you can benefit from the wisdom of hedge funds and corporate insiders.

15. Austria

Average Salary: $77,703

Austria is a great place for biomedical engineers because of its strong research and facilities. Graz University of Technology (TU Graz) has been leading the way in this field for 50 years. They have set up special institutes focused on biomedical engineering, where students and researchers work together on innovative projects. For example, they’re exploring ways to connect computers with the human brain at the Institute of Neural Engineering. Meanwhile, the Institute of Medical Engineering is improving imaging techniques to diagnose diseases better.

14. United Arab Emirates

Average Salary: $78,317

One of the examples we can use to judge UAE’s exceptional biomedical engineering industry is that Dubai Health Authority (DHA) has inaugurated a 3D Printing Lab in its Innovation Centre, aiming to provide patient-specific anatomical models for detailed pre-operative analysis and improved patient communication in DHA hospitals. Collaborating with Sinterex, a Dubai-based additive manufacturing healthcare specialist firm, DHA’s experts utilize CT or MRI scans to create digital models for 3D printing.

13. Singapore

Average Salary: $78,773

In Singapore’s biotech market, innovation continues to grow with companies like Albatroz Therapeutics, focusing on therapeutic antibodies against novel targets, enhancing tumor and arthritis treatments. Allozymes has pioneered sustainable enzyme engineering, revolutionizing manufacturing processes through microfluidics technology. Meanwhile, Gero utilizes AI to combat chronic diseases, offering longevity solutions by deciphering disease biology through machine learning algorithms.

12. Netherlands

Average Salary: $79,485

The Netherlands is one of the best countries for biomedical engineering owing to its cutting-edge research institutions, such as the University of Twente and Eindhoven University of Technology. Additionally, the Netherlands has a thriving biomedical industry, with renowned companies like Philips Healthcare headquartered in the country. 

11. Norway

Average Salary: $80,690

As one of the countries where biomedical engineers earn the most, Norway has a strong emphasis on research and innovation in the biomedical field, supported by huge investments in healthcare infrastructure and technology. This creates a demand for skilled professionals, including biomedical engineers, driving up salaries. 

10. Finland

Average Salary: $81,770

Finland’s leadership in biomedical engineering stems from its strong research infrastructure, exemplified by institutions like Aalto University and the University of Helsinki. The country’s innovation-friendly environment, promoted by entities like Tekes and Business Finland, fosters collaboration between academia and industry. 

9. Canada

Average Salary: $84,177

According to the Bureau of Labor Statistics (BLS) of Canada, biomedical engineering employment opportunities in Canada are projected to grow by 22% to 29% by 2024. In May 2018, the median annual wage for this profession was $97,470.

In Canada, biomedical engineers have numerous opportunities across various companies. One notable company is Synaptive Medical, renowned for its innovative surgical technologies focusing on brain and spine surgeries. They offer roles involving medical device development and imaging technology. Another prominent player is StarFish Medical, specializing in medical device development from concept to production. They provide a range of opportunities including designing, prototyping, and testing medical devices. 

8. Ireland

Average Salary: $84.922

Recently, the Trinity College Dublin’s Centre for Biomedical Engineering scholars excelled at the Bioengineering in Ireland 2024 conference. The event hosted over 150 delegates exchanging insights. With an average salary of $84,922, Ireland is one of the countries that pay the highest salary to biomedical engineers. 

7. Germany

Average Salary: $87,198

Renowned companies such as Siemens Healthineers and Carl Zeiss Meditec provide ample career opportunities in cutting-edge medical technology in Germany. With a strong healthcare system and emphasis on innovation, Germany offers an optimal environment for professionals to thrive. Moreover, collaborative initiatives like the German Research Foundation foster interdisciplinary research, further enhancing the country’s appeal to those in the biomedical engineering field.

6. Belgium

Average Salary: $87,745

Hosting prestigious institutions like KU Leuven and Ghent University, Belgium offers top-tier education in biomedical engineering. The country’s strategic location in Europe also facilitates access to international networks and industry partnerships, fostering innovation.  With an average salary of $87,745, Belgium is one of the highest paying countries for biomedical engineers in Europe.

Click here to see the 5 Highest Paying Countries for Biomedical Engineers.

Suggested Articles:

Disclosure: None. 15 Highest Paying Countries for Biomedical Engineers is originally published on Insider Monkey.

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

AI is eating the world—and the machines behind it are ravenous.

Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink.

Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and building the digital future. But there’s one urgent question few are asking:

Where will all of that energy come from?

AI is the most electricity-hungry technology ever invented. Each data center powering large language models like ChatGPT consumes as much energy as a small city. And it’s about to get worse.

Even Sam Altman, the founder of OpenAI, issued a stark warning:

“The future of AI depends on an energy breakthrough.”

Elon Musk was even more blunt:

“AI will run out of electricity by next year.”

As the world chases faster, smarter machines, a hidden crisis is emerging behind the scenes. Power grids are strained. Electricity prices are rising. Utilities are scrambling to expand capacity.

And that’s where the real opportunity lies…

One little-known company—almost entirely overlooked by most AI investors—could be the ultimate backdoor play. It’s not a chipmaker. It’s not a cloud platform. But it might be the most important AI stock in the US owns critical energy infrastructure assets positioned to feed the coming AI energy spike.

As demand from AI data centers explodes, this company is gearing up to profit from the most valuable commodity in the digital age: electricity.

The “Toll Booth” Operator of the AI Energy Boom

  • It owns critical nuclear energy infrastructure assets, positioning it at the heart of America’s next-generation power strategy.
  • It’s one of the only global companies capable of executing large-scale, complex EPC (engineering, procurement, and construction) projects across oil, gas, renewable fuels, and industrial infrastructure.
  • It plays a pivotal role in U.S. LNG exportation—a sector about to explode under President Trump’s renewed “America First” energy doctrine.

Trump has made it clear: Europe and U.S. allies must buy American LNG.

And our company sits in the toll booth—collecting fees on every drop exported.

But that’s not all…

As Trump’s proposed tariffs push American manufacturers to bring their operations back home, this company will be first in line to rebuild, retrofit, and reengineer those facilities.

AI. Energy. Tariffs. Onshoring. This One Company Ties It All Together.

While the world is distracted by flashy AI tickers, a few smart investors are quietly scooping up shares of the one company powering it all from behind the scenes.

AI needs energy. Energy needs infrastructure.

And infrastructure needs a builder with experience, scale, and execution.

This company has its finger in every pie—and Wall Street is just starting to notice.

Wall Street is noticing this company also because it is quietly riding all of these tailwinds—without the sky-high valuation.

While most energy and utility firms are buried under mountains of debt and coughing up hefty interest payments just to appease bondholders…

This company is completely debt-free.

In fact, it’s sitting on a war chest of cash—equal to nearly one-third of its entire market cap.

It also owns a huge equity stake in another red-hot AI play, giving investors indirect exposure to multiple AI growth engines without paying a premium.

And here’s what the smart money has started whispering…

The Hedge Fund Secret That’s Starting to Leak Out

This stock is so off-the-radar, so absurdly undervalued, that some of the most secretive hedge fund managers in the world have begun pitching it at closed-door investment summits.

They’re sharing it quietly, away from the cameras, to rooms full of ultra-wealthy clients.

Why? Because excluding cash and investments, this company is trading at less than 7 times earnings.

And that’s for a business tied to:

  • The AI infrastructure supercycle
  • The onshoring boom driven by Trump-era tariffs
  • A surge in U.S. LNG exports
  • And a unique footprint in nuclear energy—the future of clean, reliable power

You simply won’t find another AI and energy stock this cheap… with this much upside.

This isn’t a hype stock. It’s not riding on hope.

It’s delivering real cash flows, owns critical infrastructure, and holds stakes in other major growth stories.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 100+% Return within 12 to 24 months.

We’re now offering month-to-month subscriptions with no commitments.

For a ridiculously low price of just $9.99 per month, you can unlock our in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…